Maternal diet-induced obesity during pregnancy alters lipid supply to mouse E18.5 fetuses and changes the cardiac tissue lipidome in a sex-dependent manner.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
13 01 2022
Historique:
received: 03 04 2021
accepted: 12 01 2022
pubmed: 14 1 2022
medline: 16 3 2022
entrez: 13 1 2022
Statut: epublish

Résumé

Maternal obesity during pregnancy has immediate and long-term detrimental effects on the offspring heart. In this study, we characterized the cardiac and circulatory lipid profiles in late gestation E18.5 fetuses of diet-induced obese pregnant mice and established the changes in lipid abundance and fetal cardiac transcriptomics. We used untargeted and targeted lipidomics and transcriptomics to define changes in the serum and cardiac lipid composition and fatty acid metabolism in male and female fetuses. From these analyses we observed: (1) maternal obesity affects the maternal and fetal serum lipidome distinctly; (2) female fetal heart lipidomes are more sensitive to maternal obesity than males; (3) changes in lipid supply might contribute to early expression of lipolytic genes in mouse hearts exposed to maternal obesity. These results highlight the existence of sexually dimorphic responses of the fetal heart to the same in utero obesogenic environment and identify lipids species that might mediate programming of cardiovascular health.

Identifiants

pubmed: 35025731
doi: 10.7554/eLife.69078
pii: 69078
pmc: PMC8794468
doi:
pii:

Banques de données

GEO
['GSE162185']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_UU_12012/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00025/6
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/12/33167
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0902052
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/4
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208363/Z/17/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/56/35177
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/12/64/30001
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M027252/1
Pays : United Kingdom

Informations de copyright

© 2022, Pantaleão et al.

Déclaration de conflit d'intérêts

LP, II, SF, EL, AH, TA, HB, BJ, AC, AW, MB, AK, DF, SO No competing interests declared

Références

Sci Rep. 2018 Sep 11;8(1):13614
pubmed: 30206284
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11439-44
pubmed: 23716672
J Intern Med. 2007 May;261(5):412-7
pubmed: 17444880
Cardiovasc Res. 2018 Aug 1;114(10):1372-1384
pubmed: 29635288
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Circ Heart Fail. 2014 Jan;7(1):172-83
pubmed: 24284026
Eur J Biochem. 1998 May 1;253(3):614-8
pubmed: 9654057
J Am Heart Assoc. 2020 Apr 21;9(8):e011541
pubmed: 32308111
Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1212-E1223
pubmed: 30300011
Anal Bioanal Chem. 2018 Mar;410(7):1965-1976
pubmed: 29411084
J Chromatogr A. 2020 May 10;1618:460849
pubmed: 31928769
Nucleic Acids Res. 2007 Jan;35(Database issue):D527-32
pubmed: 17098933
Anal Bioanal Chem. 2020 May;412(12):2851-2862
pubmed: 32144454
Gigascience. 2019 Jun 1;8(6):
pubmed: 31141612
Commun Biol. 2021 Feb 5;4(1):163
pubmed: 33547386
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Front Physiol. 2018 Jul 19;9:959
pubmed: 30072919
Circulation. 2021 Apr 20;143(16):1614-1628
pubmed: 33682422
Reproduction. 2017 Mar;153(3):R97-R108
pubmed: 27864335
Br J Nutr. 2002 Oct;88(4):355-63
pubmed: 12323085
J Mol Cell Cardiol. 2013 Feb;55:111-6
pubmed: 22982026
PLoS One. 2018 Apr 10;13(4):e0194797
pubmed: 29634782
Diabetologia. 2020 Feb;63(2):324-337
pubmed: 31773193
Cell Rep. 2018 Sep 4;24(10):2757-2772
pubmed: 30184508
J Proteome Res. 2019 Jun 7;18(6):2397-2410
pubmed: 30887811
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572
pubmed: 28411170
Horm Mol Biol Clin Investig. 2016 May 1;26(2):109-27
pubmed: 26351960
Mol Metab. 2021 Jan;43:101116
pubmed: 33212270
Biochemistry. 2005 Apr 5;44(13):5234-45
pubmed: 15794660
Nutr Rev. 2013 Oct;71 Suppl 1:S42-54
pubmed: 24147924
Mol Metab. 2018 Sep;15:8-19
pubmed: 29773464
PLoS Med. 2019 Sep 13;16(9):e1002910
pubmed: 31518348
J Physiol. 2018 Dec;596(23):5823-5837
pubmed: 29516496
Methods Enzymol. 2014;542:391-405
pubmed: 24862277
Sci Rep. 2017 Mar 14;7:44650
pubmed: 28291256
Nutrients. 2019 May 20;11(5):
pubmed: 31137537
Sci Rep. 2019 Nov 26;9(1):17621
pubmed: 31772245

Auteurs

Lucas C Pantaleão (LC)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Isabella Inzani (I)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Samuel Furse (S)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom.

Elena Loche (E)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Antonia Hufnagel (A)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Thomas Ashmore (T)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Heather L Blackmore (HL)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Benjamin Jenkins (B)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom.

Asha A M Carpenter (AAM)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Ania Wilczynska (A)

Cancer Research UK Beatson Institute, Glasgow, United Kingdom.
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Glasgow, United Kingdom.
Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Albert Koulman (A)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.
Core Metabolomics and Lipidomics Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Addenbrooke's Treatment Centre, Cambridge, United Kingdom.

Denise S Fernandez-Twinn (DS)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Susan E Ozanne (SE)

Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH